<code id='63C4915263'></code><style id='63C4915263'></style>
    • <acronym id='63C4915263'></acronym>
      <center id='63C4915263'><center id='63C4915263'><tfoot id='63C4915263'></tfoot></center><abbr id='63C4915263'><dir id='63C4915263'><tfoot id='63C4915263'></tfoot><noframes id='63C4915263'>

    • <optgroup id='63C4915263'><strike id='63C4915263'><sup id='63C4915263'></sup></strike><code id='63C4915263'></code></optgroup>
        1. <b id='63C4915263'><label id='63C4915263'><select id='63C4915263'><dt id='63C4915263'><span id='63C4915263'></span></dt></select></label></b><u id='63C4915263'></u>
          <i id='63C4915263'><strike id='63C4915263'><tt id='63C4915263'><pre id='63C4915263'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:explore    Page View:9
          King Street Properties’ Pathway Devens campus. -- biotech coverage from STAT
          Pat Greenhouse/Globe Staff

          MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.

          On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.

          advertisement

          One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Colorectal cancer study finds potential in overlooked immune cell
          Colorectal cancer study finds potential in overlooked immune cell

          Stainingrevealsdifferentimmunecellsinahealthyhumancolon.CourtesyOliviaNewton-JohnCancerResearchinsti

          read more
          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more

          In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

          CourtesyBristolMyersSquibbBristolMyersSquibbsaidthatitwouldpurchaseMiratiTherapeutics,makerofthecanc